These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23916330)

  • 81. Silver-embedded screens in the intensive care unit. A new tool to control multi-drug resistant bacterial cross-transmission.
    Ruiz J; Ramirez P; Villarreal E; Gordon M; Cuesta S; Piñol M; Frasquet J; Castellanos Á
    Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1505-1509. PubMed ID: 28321578
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Surveillance and management of multidrug-resistant microorganisms.
    Orsi GB; Falcone M; Venditti M
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):653-79. PubMed ID: 21819331
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Control of multiresistant bacteria diffusion in institutions].
    Blot S
    Soins Gerontol; 2006; (61):36-8. PubMed ID: 17063854
    [No Abstract]   [Full Text] [Related]  

  • 84. Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States.
    Magill SS; Dumyati G; Ray SM; Fridkin SK
    Emerg Infect Dis; 2015 Sep; 21(9):1537-42. PubMed ID: 26291035
    [TBL] [Abstract][Full Text] [Related]  

  • 85. What strategies are in place to control microbial burden in hospital environments and how could these change in the future?
    Chirca I; Salgado CD
    Future Microbiol; 2013 Sep; 8(9):1051-4. PubMed ID: 24020731
    [No Abstract]   [Full Text] [Related]  

  • 86. Why is antibiotic resistance a deadly emerging disease?
    Courvalin P
    Clin Microbiol Infect; 2016 May; 22(5):405-7. PubMed ID: 26806259
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Antibiotics save lives--but bacteria are inevitable.
    Spencer RC
    J Perioper Pract; 2008 Jul; 18(7):260. PubMed ID: 18710121
    [No Abstract]   [Full Text] [Related]  

  • 88. Bio-Kil, a nano-based disinfectant, reduces environmental bacterial burden and multidrug-resistant organisms in intensive care units.
    Lee WS; Hsieh TC; Shiau JC; Ou TY; Chen FL; Liu YH; Yen MY; Hsueh PR
    J Microbiol Immunol Infect; 2017 Oct; 50(5):737-746. PubMed ID: 27262208
    [TBL] [Abstract][Full Text] [Related]  

  • 89. What you need to know about SARS now.
    Dreher HM; Dean JL; Moriarty DM; Kaiser R; Willard R; O'Donnell S; Virella J; O'Brien C; Marcolongo C; Regn K; Constans C; Sowden R; Phung L
    Nursing; 2004 Jan; 34(1):58-63; quiz, 63-4. PubMed ID: 14722438
    [No Abstract]   [Full Text] [Related]  

  • 90. [SARS: no need to panic, just be careful].
    Bricaire F
    Presse Med; 2003 May; 32(17):772-3. PubMed ID: 12856321
    [No Abstract]   [Full Text] [Related]  

  • 91. Antibiotic resistance. An impending crisis.
    Mah MW; Memish ZA
    Saudi Med J; 2000 Dec; 21(12):1125-9. PubMed ID: 11360084
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Planning for epidemics--the lessons of SARS.
    Weinstein RA
    N Engl J Med; 2004 Jun; 350(23):2332-4. PubMed ID: 15175434
    [No Abstract]   [Full Text] [Related]  

  • 93. SELECTED EPIDEMICS & EMERGING PATHOGENS - PREVENTIVE STRATEGIES.
    Dis Mon; 2017 Sep; 63(9):272-274. PubMed ID: 29737285
    [No Abstract]   [Full Text] [Related]  

  • 94. Emerging infections: respiratory syncytial virus.
    Goldrick BA
    Am J Nurs; 2004 Nov; 104(11):54-6. PubMed ID: 15616451
    [No Abstract]   [Full Text] [Related]  

  • 95. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
    Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
    Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Beyond MRSA: VISA and VRSA: what will ward off these pathogens in health care facilities?
    Todd B
    Am J Nurs; 2006 Apr; 106(4):28-30. PubMed ID: 16575232
    [No Abstract]   [Full Text] [Related]  

  • 97. Enhancing efficacy of existing antibacterials against selected multiple drug resistant bacteria using cinnamic acid-coated magnetic iron oxide and mesoporous silica nanoparticles.
    Akbar N; Kawish M; Jabri T; Khan NA; Shah MR; Siddiqui R
    Pathog Glob Health; 2022 Oct; 116(7):438-454. PubMed ID: 34937524
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Moxifloxacin and Sulfamethoxazole-Based Nanocarriers Exhibit Potent Antibacterial Activities.
    Akbar N; Gul J; Siddiqui R; Shah MR; Khan NA
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439014
    [TBL] [Abstract][Full Text] [Related]  

  • 99. War on terror cells: killing the host that harbours 'superbugs' is an infection control strategy in our fight against infectious diseases.
    Khan NA; Siddiqui R
    Pathog Glob Health; 2014 Jan; 108(1):4-10. PubMed ID: 24548155
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Infection control strategy by killing drug-resistant bacteria.
    Siddiqui R; Khan NA
    Pathog Glob Health; 2013 Jul; 107(5):215-6. PubMed ID: 23916330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.